Overall rank by patents
#29,569
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).
The verdict
Nalge holds 9 US patents across 9 technology areas, rank #29,569 of 50,000 tracked assignees.
Nalge Nunc International Corporation has been granted 9 US utility patents between 2015 and 2025, placing Nalge Nunc International Corporation at rank #29,569 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.4 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Nalge Nunc International Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Nalge sits between NUTS Holdings, Llc (9 patents, rank #29,565) and Nanodx, Inc. (9 patents, rank #29,573) - the closest US assignees by grant volume. The composite Innovation Score of 26.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nalge Nunc International Corporation's 10.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nalge Nunc International Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NUTS HOLDINGS, LLC
9 patents
NXT Biomedical, LLC
9 patents
NYSE American LLC
9 patents
Nagano Automation Co., Ltd.
9 patents
Nammi Therapeutics, Inc.
9 patents
Nanjing Zgmicro Company Limited
9 patents
NanoAL LLC
9 patents
NanoDX, Inc.
9 patents
Nalge Nunc International Corporation
9 patents
What this shows Nalge holds 9 patents at rank #29,569, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,569 in granted patent volume.
Other assignees with the most granted patents in Nalge's primary technology class.
Nalge's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
26 Top 81% higher than 19% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 11.1% |
| 2017 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
| 2020 | 1 | 11.1% |
| 2021 | 2 | 22.2% |
| 2022 | 1 | 11.1% |
| 2025 | 1 | 11.1% |
Top 9 of 9 technology areas
Overall rank by patents
#29,569
Across all tracked assignees
26.2 out of 100
How to use this portfolio
Nalge's 9 grants land it in the top 81% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.